EN
HI

BAL PHARMA Share price

BALPHARMA

HealthcareSmall

100.95

1.20 (-1.17%)
NSE
BSE
Last updated on 2 May, 2025 | 15:51 IST
BUYSELL
Today's High

100.23

Today's Low

103.03

52 Week Low

157.98

52 Week High

157.98

The current prices are delayed, login to your account for live prices

Bal Pharma Chart

BAL PHARMA Share Key Metrics

Volume
20357.00
Market Cap
160.72 CR
LTQ@LTP
1@100.95
ATP
101.52
Var Margin
2606
Circuit Range
91.93-112.36
Delivery %
34.48
Value
20.67 L
ASM/GSM
No
Market Lot
1

BAL PHARMA Futures & Options

Data Not Found

BAL PHARMA Corporate Actions

DateAgenda
2025-02-13Quarterly Results & Fund Raising
DateEvent TypeAgenda
2025-02-13Board MeetingQuarterly Results & Fund Raising

BAL PHARMA News

Bal Pharma Standalone March 2024 Net Sales at Rs 94.58 crore, up 15.38% Y-o-Y

Jun 11 2024 12:51:53
Read More

About BAL PHARMA

NSE : 13441  
BSE : 524824  
ISIN : INE083D01012  

Bal Pharma Ltd. (BPHL) was originally incorporated as aprivate limited company on the 19th May 1987. BPHL on22nd Mar 1990 took over a pharmaceutical productsmanufacturing unit located at 21-22 Bommasandra Industrialarea Bangalore District. The unit was taken over throughKarnataka State Finance Corporation for a consideration ofRs.25.18 lacs. After take over BPHL commenced theactivity of manufacture of formulations at the above plantfrom Sep 1991. The constitution of the company has beenconverted into a public limited company on 25.7.1994. Freshcertificate of incorporation has been obtained on 9th Aug1994.Main objects.The Main objects of the Company set out in the Memorandumof Association of the Company are:1. To Carry on the business of analytical chemistsdruggists drysalters and manufacturers importersrepackers of and dealers in pharmaceutical medicinalchemical biological and biochemical and electrolyticdrugs chemicals ingredients products and compounds.2. To manufacture prepare import export buy sellsupply and distribute store stock maintain andotherwise handle. deal in and carry on business of allkinds and varieties of patent medicines drugs mixturestablets capsules pills powders pharmaceuticalschemicals medicals and medicinal products preparationsand materials sterilised injections vaccines seraimmunogens phylacogens and surgical dressings.3. To purchase produce manufacture grow raise sell orotherwise handle raw materials of all kinds for manufactureof pharmaceuticals medicines and drugs.Present business of the company.BPHL is engaged in the manufacture of Pharmaceuticalformulations viz Paracetamol Aluminium Hydroxide PovidoneIodine Alprazolam Gliclazide GriseofulvinLactobacillus Rifampicin Piroxicam and Amoxycillin etc.INFRASTRUCTURE AVAILABLEThe production facilities for pharmaceutical formulationsare set up at 21-22 Bommasandra Industrial areaBangalore. The factory is located at a distance of 20 KMsfrom Bangalore.It has facilities for manufacture of tablets capsulesliquids and ointments. The equipments installed for themanufacture of above products are as under.(a) The tabletting plant is equipped with planetary mixerstray and fluid bed dryers rotary compression machines andblister packing machines.(b) The capsule manufacturing plant is equipped withsifters multimills blenders hand filling machinessemi-automatic filling machines and capsule polishingmachines.(c) The ointment manufacturing plant is equipped with aplanetory mixer and an automatic tube filling machine.(d) The equipments in the oral liquid area includehomogenizer colloidal mill filter process rotary bottlewashing machine and automatic labelling machine.(e) The plant is equipped with standard measuring devicesair conditioners The facilities are modern and conform tothe latest ''Good manufacturing practices'' (GMP). Thecompany holds a valid GMP certificate. The GMP certifiesthat the company has the required technical personnelquality management system premises & equipmentsdocumentation quality control and inspection facilitiesfor manufacture of quality products as per specifications.The existing infrastructure would enable the company toproduce the following products at 100% capacityutilisation.Tablets 250 Million Nos p.a.Capsules 90 Million Nos p.a.Liquids 750 Kilo Litres p.aOintments 75 Metric Tonnes p.a.The unit is equipped with facilities for quality testing ofthe company''s products.

BAL PHARMA Management

NamePosition
Mr. Shailesh D Siroya Managing Director
Mr. Himesh Virupakshaya Executive Director
Mr. Jatish Sheth Independent Director
Dr. C V Srinivas Independent Director
Ms. Nicloa Neeladri Independent Director
Read More

BAL PHARMA FAQs

The Buying Price of BAL PHARMA share is 72.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy BAL PHARMA share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of BAL PHARMA shares is 15.32. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio BAL PHARMA shares is 1.47. Useful to assess the stock's value relative to its book value.

To assess BAL PHARMA’s valuation compare Sector P/E, P/B which are 34.02 & 4.86 with sector averages, along with growth rates and financial metrics.

The Market Cap of BAL PHARMA is 160.72 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of BAL PHARMA share price is 157.98 & 78.06. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.